Anika Therapeutics (ANIK) Free Cash Flow (2010 - 2026)
Anika Therapeutics (ANIK) reported Free Cash Flow of -$4.9 million for Q1 2026, down 675.47% year-over-year from $851644.8 in Q1 2025, and down 222.31% quarter-over-quarter from $4.0 million in Q4 2025.
Anika Therapeutics (ANIK) Free Cash Flow (2010 - 2026) Analysis & Trends
Anika Therapeutics (ANIK) has 17 years of Free Cash Flow data on file, last reported at -$4.9 million in Q1 2026.
- Free Cash Flow for Q1 2026 came in at -$4.9 million, down 675.47% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.3 million (up 28.14% YoY), and the FY2025 annual result was $10.5 million, up 120.86% from the prior year.
- Free Cash Flow eased to -$4.9 million in Q1 2026 per ANIK's latest filing, from $4.0 million in the prior quarter.
- Over five years, Free Cash Flow peaked at $11.1 million in Q3 2025 and troughed at -$7.0 million in Q2 2023.
- A 5-year average of $710764.7 and a median of $1.0 million in 2022 frame the typical range for Free Cash Flow.
- The sharpest annual moves came in 2023 and 2025: Free Cash Flow sank 706.62% in 2023, then jumped 192.76% in 2025.
- A 5-year view of Free Cash Flow shows it stood at $5.3 million in 2022, then gained by 20.26% to $6.4 million in 2023, then grew by 14.98% to $7.4 million in 2024, then tumbled by 45.63% to $4.0 million in 2025, then plunged by 222.31% to -$4.9 million in 2026.
- Business Quant data shows ANIK's Free Cash Flow at -$4.9 million in Q1 2026, $4.0 million in Q4 2025, and $11.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -208.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 291.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 362.50 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 136.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -38.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -169.83 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 80.53 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 123.09 Mn |
| 10 | Anika Therapeutics | 197.89 Mn | 131.10 Mn | 19.00 Mn | -4.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.90 Mn |
| Mar 31, 2026 | -4.90 Mn |
| Dec 31, 2025 | 4.01 Mn |
| Dec 31, 2025 | 4.01 Mn |
| Sep 30, 2025 | 11.13 Mn |
| Sep 30, 2025 | 11.13 Mn |
| Jun 30, 2025 | -3.98 Mn |
| Jun 30, 2025 | -3.98 Mn |
| Mar 31, 2025 | -632,000.00 |
| Mar 31, 2025 | -632,000.00 |
| Dec 31, 2024 | 7.37 Mn |
| Dec 31, 2024 | 7.37 Mn |
| Sep 30, 2024 | 3.80 Mn |
| Sep 30, 2024 | 3.80 Mn |
| Jun 30, 2024 | -5.66 Mn |
| Jun 30, 2024 | -5.66 Mn |
| Mar 31, 2024 | -748,000.00 |
| Mar 31, 2024 | -748,000.00 |
| Dec 31, 2023 | 6.41 Mn |
| Dec 31, 2023 | 6.41 Mn |